Zobrazeno 1 - 10
of 71
pro vyhledávání: '"João Roberto de, Sá"'
Autor:
Marcello Casaccia Bertoluci, Wellington S. Silva Júnior, Fernando Valente, Levimar Rocha Araujo, Ruy Lyra, João Jácome de Castro, João Filipe Raposo, Paulo Augusto Carvalho Miranda, Cesar Luiz Boguszewski, Alexandre Hohl, Rui Duarte, João Eduardo Nunes Salles, José Silva-Nunes, Jorge Dores, Miguel Melo, João Roberto de Sá, João Sérgio Neves, Rodrigo Oliveira Moreira, Marcus Vinícius Bolívar Malachias, Rodrigo Nunes Lamounier, Domingos Augusto Malerbi, Luis Eduardo Calliari, Luis Miguel Cardoso, Maria Raquel Carvalho, Hélder José Ferreira, Rita Nortadas, Fábio Rogério Trujilho, Cristiane Bauermann Leitão, José Augusto Rodrigues Simões, Mónica Isabel Natal dos Reis, Pedro Melo, Mafalda Marcelino, Davide Carvalho
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-37 (2023)
Abstract Background The management of antidiabetic therapy in people with type 2 diabetes (T2D) has evolved beyond glycemic control. In this context, Brazil and Portugal defined a joint panel of four leading diabetes societies to update the guideline
Externí odkaz:
https://doaj.org/article/7a33d32c96384dd98a2573e4083ce617
Autor:
João Roberto de Sá, Erika Bevilaqua Rangel, Luis Henrique Canani, Andrea Carla Bauer, Gustavo Monteiro Escott, Themis Zelmanovitz, Marcello Casaccia Bertoluci, Sandra Pinho Silveiro
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-28 (2022)
Abstract Background Diabetic kidney disease is the leading cause of end-stage renal disease and is associated with increased morbidity and mortality. This review is an authorized literal translation of part of the Brazilian Diabetes Society (SBD) Gui
Externí odkaz:
https://doaj.org/article/8770db0e237149a2b68f4804c24af12e
Autor:
Débora Dias de Lucena, Renato de Marco, João Roberto de Sá, José Osmar Medina-Pestana, Maria Gerbase-DeLima, Érika Bevilaqua Rangel
Publikováno v:
Brazilian Journal of Transplantation, Vol 24, Iss 1 (2021)
Introdução: Diabetes mellitus pós-transplante (DMPT) tem impacto na morbidade e na mortalidade em receptores de transplante renal, uma vez que aumenta o risco de complicações cardiovasculares e de perda do enxerto renal. Os fatores de risco para
Externí odkaz:
https://doaj.org/article/0220dbff721f4d6c986bc31dd7dd4be7
Publikováno v:
Journal of Diabetes Research, Vol 2020 (2020)
Modifiable and nonmodifiable risk factors for developing posttransplant diabetes mellitus (PTDM) have already been established in kidney transplant setting and impact adversely both patient and allograft survival. We analysed 450 recipients of living
Externí odkaz:
https://doaj.org/article/cfc6d82bd31346a494cb20d7936876d4
Autor:
Fernanda de Oliveira Procópio, Érika Bevilaqua Rangel, Bartira de Aguiar Roza, João Roberto de Sá, Janine Schirmer
Publikováno v:
Acta Paulista de Enfermagem. 36
Autor:
Maria Gerbase-DeLima, Débora Dias de Lucena, Renato de Marco, João Roberto de Sá, Jose O. Medina-Pestana, Erika B Rangel
Publikováno v:
Brazilian Journal of Transplantation. 24:6-14
Introdução: Diabetes mellitus pós-transplante (DMPT) tem impacto na morbidade e na mortalidade em receptores de transplante renal, uma vez que aumenta o risco de complicações cardiovasculares e de perda do enxerto renal. Os fatores de risco para
Publikováno v:
Frontiers in Neurology, Vol 8 (2017)
BackgroundPainful diabetic neuropathy (PDN) is a serious, polymorphic, and prevalent complication of diabetes mellitus. Most PDN treatment guidelines recommend a selection of drugs based on patient comorbidities. Despite the large numbers of medicati
Externí odkaz:
https://doaj.org/article/81835c2d2f9c4f0e9121bc5e1b70f023
Autor:
Patricia Dualib, Luana Aparecida Ramaldes, João Roberto de Sá, Sarah Simaan dos Santos, Sergio Atala Dib
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 65, Iss 2, Pp 231-236 (2021)
SUMMARY Ketosis-prone type 2 diabetes (KPD) is an emerging form of diabetes mellitus characterized by unprovoked ketoacidosis, absence of autoimmunity and beta-cell dysfunction. The KPD may improve after initial glycemic compensation and evolve to ex
Autor:
Cláudio S. Melaragno, Adriano Miziara Gonzalez, Marcelo Moura Linhares, Erika B Rangel, Jose O. Medina-Pestana, Rubens Marcella-Neto, João Roberto de Sá, Alcides Augusto Salzedas-Neto
Publikováno v:
Transplantation Proceedings. 52:1376-1379
Background Pancreas transplant is an effective treatment for insulin-dependent diabetic individuals with end-stage renal disease, yet immunosuppression-associated adverse events may adversely affect patient and graft survival. The aim of the study wa